What is Collegium Pharmaceutical, Inc.'s total revenue?

Collegium Pharmaceutical, Inc. (COLL) reported total revenue of $193.52M in Q1 2026.

How has Collegium Pharmaceutical, Inc.'s total revenue changed year-over-year?

Collegium Pharmaceutical, Inc.'s total revenue increased by 8.9% year-over-year, from $177.76M to $193.52M.

What is the long-term trend for Collegium Pharmaceutical, Inc.'s total revenue?

Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s total revenue has grown at a 29.6% compound annual growth rate (CAGR), from $276.87M to $780.57M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Collegium Pharmaceutical, Inc. COLL Total Revenue

Total Revenue at other companies

Indivior Pharmaceuticals, Inc. INDV

$317M+19.2%

Catalyst PharmaceuticalCPRX

$149.39M+5.6%

Avanos MedicalAVNS

$182.2M+8.8%

Pacira BioSciences, Inc.PCRX

$177.38M+5.0%

Supernus PharmaceuticalsSUPN

$207.71M+38.6%

Theravance BiopharmaTBPH

$17.7M+15.0%

Segments

By product

See full

Belbuca$52.65M+1.9%

Xtampza ER$50.77M—

Jornay PM$38.89M+36.3%

Nucynta IR$26.08M-4.9%

Nucynta ER$18.23M-7.4%

Symproic and other$14.45M—

By segment

See full

Segment$193.52M+8.9%

Other financials

Income statement

See full

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

See full

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

See full

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

See full

Market cap$1.15B+9.5%

Enterprise value$869.67M-9.8%

P/E15.4×-8.6×

P/S1.5×-0.1×

Profitability

See full

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

Net margin9.4%+2.8pp

FCF margin41.4%+10.4pp

Returns & leverage

See full

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s total revenue?: Collegium Pharmaceutical, Inc. (COLL) reported total revenue of $193.52M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s total revenue changed year-over-year?: Collegium Pharmaceutical, Inc.'s total revenue increased by 8.9% year-over-year, from $177.76M to $193.52M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s total revenue?: Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s total revenue has grown at a 29.6% compound annual growth rate (CAGR), from $276.87M to $780.57M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.